AI signal comparison: JOHNSON & JOHNSON vs ABBOTT LABORATORIES
| Metric | JNJ | ABT |
|---|---|---|
| Company | JOHNSON & JOHNSON | ABBOTT LABORATORIES |
| Sector | Healthcare | Healthcare |
| Industry (SIC) | Pharmaceutical Preparations | Pharmaceutical Preparations |
| Insider Activity | elevated | elevated |
| Recent Form 4 Filings | 12 | 14 |
| Recent 8-K Filings | 2 | 1 |
| Filing Frequency | moderate | normal |
| Signals Tracked | 20 | 20 |
| Times Traded | 0 | 0 |
| Total P&L | $0 | $0 |
| Dark Pool Activity | monitoring | monitoring |
| Incorporated | NJ | IL |
Fin45's AI agent monitors both JNJ and ABT across all 11 signal categories. Both operate in the Healthcare sector, meaning they share sector-level signals (rotation, correlation) but have independent company-level signals (insider activity, filings, options flow).
JNJ shows elevated insider activity (12 recent Form 4 filings) compared to ABT's elevated level (14 recent Form 4s). Higher filing frequency in ABT may indicate more active insider positioning.
JNJ has 2 recent 8-K filings (material events) vs ABT's 1. 8-K filings signal corporate events that could affect signal scoring: executive changes, material agreements, acquisitions, or regulatory actions.
Because both JNJ and ABT are in the Healthcare sector, Fin45's 40% sector cap limits combined exposure. The AI agent accounts for correlation between same-sector holdings when sizing positions — holding both simultaneously would require each to be sized smaller.
When both JNJ and ABT show high-conviction signals simultaneously, the agent evaluates: